Taros Chemicals als Innovation Partner auf der Drug Discovery 2025

Von der Molekülidee zur Therapie – Innovation beginnt im Labor. Wir freuen uns, bekannt zu geben, dass Taros Chemicals auf der ELRIG Drug Discovery 2025 in Liverpool vertreten sein wird.

Unser Head Medicinal Chemistry, Dr. Anil Agarwal, ist vor Ort und wird sich intensiv mit führenden Expert:innen aus den Bereichen Wirkstoffforschung und frühe Arzneimittelentwicklung austauschen. Gemeinsam wollen wir neue Ansätze erkunden, Herausforderungen adressieren und diskutieren, wie Zusammenarbeit Durchbrüche ermöglichen kann – vom Labor bis zur realen Therapie.

Warum Taros auf der Drug Discovery 2025 treffen?

    • Taros verfügt über jahrzehntelange Expertise in synthetischer Chemie, medizinischer Chemie und skalierbaren Lösungen, mit denen wir gemeinsam Fortschritte beschleunigen können.

    • Fortschritte in der Wirkstoffforschung entstehen durch den Dialog zwischen Wissenschaft, Industrie und Technologiepartnern.

Was erwartet Sie bei Taros auf der Drug Discovery 2025?

Auf der ELRIG Drug Discovery 2025 trifft sich ein internationales Publikum aus Wissenschaft, Biotechnologie, Pharma und Technologiepartnern in Liverpool. Die Konferenz bietet eine hervorragende Plattform, um Ideen auszutauschen, Netzwerke zu stärken und zu zeigen, welchen Beitrag Taros im Bereich synthetische Chemie, MedChem und skalierbarer Innovation in den Lebenswissenschaften leistet.

Veranstaltungsdetails

  • Veranstaltung: ELRIG Drug Discovery 2025

  • Datum: 21.–22. Oktober 2025

  • Ort: Liverpool, UK

Treten Sie mit uns in Kontakt!

About Taros

Staff Members
0
Ph.D. Degree
0 %
Nationalities Inhouse
0
Projects Executed
> 12400
Years Active
"Injections" Needed
999000

Latest News

Discovery Chemistry services to materialize your ideas

At Taros we regularly perform contract research with an emphasis on the design and synthesis of novel building blocks, intermediates and final compounds for several applications. We pride ourselves on a 20 year track record of success in supporting diverse industries with their chemistry and innovation challenges. Our scientists specialize in organic and organometallic synthesis including polymers, from lab scale to pilot quantities. Taros operates a customer-centric and flexible business model providing our diverse clients with customized innovative discovery chemistry services:

Biotechs

Biotechs simply concentrate on their research and development tasks while our experienced chemists take care of all related synthetic chemistry challenges.

Medtech and Healthcare

From new release mechanisms in band-aid material to the development of chemistry for innovative dual modes of action to help make use of new imaging techniques (PET).

Display Technologies

Innovative display technologies require performance chemicals that allow tomorrow’s visual applications in handheld devices, car interfaces or further intelligent equipment.

Pharma

Providing innovative but cost efficient early drug discovery services and technologies to our pharma customers is what drives our multidisciplinary scientists at Taros.

Chemical Industry

From literature research to pilot plant – we deliver sophisticated chemicals with full IP to our customers to help them achieve their product development goals.

Coatings and Dyes

Your R&D has a specific idea about how the surface should perform by modulating the coating or the curing? Get in touch with our scientists to discuss your chemistry challenge.

Research Institutes and Academia

Great academic research often requires industrial backing and excellent synthesis capacities to bring ideas to the market – for many years we have been closing that gap.

Flavors and Cosmetics

Get in touch with us if you’d like to discuss the development of new or the improvement of existing synthetic molecules for fragrances, skin care applications or aroma molecules.

Consumer Goods

Smarter consumer goods require both improved properties and chemicals that provide an acceptable ecological footprint during their entire life cycle.

We provide long-term added value to our diverse customers through discovery chemistry services and contract research

Our contract research focuses on holistic and cost-effective solutions of the highest quality for the global marketplace. We are inspired to provide exceptional added value to our customers’ R&D processes by anticipating hurdles foreseeing cost and lead time reductions. Thereby we facilitate competitive and “early-to-market” advantages. With our state-of-the-art lab facilities and our scientists (of which 65% hold a Ph.D. in Chemistry), we are committed to serve the diverse needs of our customers with discovery chemistry services in drug discovery, custom synthesis and specialty or performance chemicals. More than 13,000 synthesis, research and process chemistry projects have been delivered successfully to our ever-growing global customer base.
Taros Chemicals GmbH & Co. KG receives funding from the program European Regional Development Fund (ERDF / EFRE) by the state of North Rhine-Westphalia and the Europen Union.
Nach oben scrollen
Datenschutz-Übersicht

Diese Website verwendet Cookies, damit wir dir die bestmögliche Benutzererfahrung bieten können. Cookie-Informationen werden in deinem Browser gespeichert und führen Funktionen aus, wie das Wiedererkennen von dir, wenn du auf unsere Website zurückkehrst, und hilft unserem Team zu verstehen, welche Abschnitte der Website für dich am interessantesten und nützlichsten sind.